Cargando…

Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion

SIMPLE SUMMARY: Barth syndrome (BTHS) is a disease that affects energy production. It results from mutations on the X chromosome, and thus it mainly affects males since they have only one copy (females have two X chromosomes). Although BTHS is rare, the consequences can be severe. BTHS affects the h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomczewski, Michelle V., Chan, John Z., Al-Majmaie, Duaa M., Liu, Ming Rong, Cocco, Alex D., Stark, Ken D., Strathdee, Douglas, Duncan, Robin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525480/ https://www.ncbi.nlm.nih.gov/pubmed/37759637 http://dx.doi.org/10.3390/biology12091238

Ejemplares similares

Phenotypic Characterization of Male Tafazzin-Knockout Mice at 3, 6, and 12 Months of Age
por: Tomczewski, Michelle V., et al.
Publicado: (2023)

Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis
por: Cadalbert, Laurence C., et al.
Publicado: (2015)

N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics
por: Chan, John Z., et al.
Publicado: (2022)

X Chromosome Inactivation Pattern and Pregnancy Outcome of Female Carriers of Pathogenic Heterozygous X-Linked Deletions
por: Zhao, Yuanyin, et al.
Publicado: (2021)

Role of Tafazzin in Mitochondrial Function, Development and Disease
por: Chin, Michael T., et al.
Publicado: (2020)

Barth syndrome mutations that cause tafazzin complex lability
por: Claypool, Steven M., et al.
Publicado: (2011)

Drosophila tafazzin mutants have impaired exercise capacity
por: Damschroder, Deena, et al.
Publicado: (2018)

Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells
por: de Taffin de Tilques, Maxence, et al.
Publicado: (2018)

Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis
por: Chen, Mei, et al.
Publicado: (2017)

Molecular Pathogenesis of EBV Susceptibility in XLP as Revealed by Analysis of Female Carriers with Heterozygous Expression of SAP
por: Palendira, Umaimainthan, et al.
Publicado: (2011)

Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins
por: Claypool, Steven M., et al.
Publicado: (2006)

New C-Terminal Conserved Regions of Tafazzin, a Catalyst of Cardiolipin Remodeling
por: Shilovsky, Gregory A., et al.
Publicado: (2019)

Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid
por: Fernandes, Maria F., et al.
Publicado: (2022)

Heterozygous SOD2 deletion selectively impairs SERCA function in the soleus of female mice
por: Braun, Jessica L., et al.
Publicado: (2022)

Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers
por: Castelo Rueda, Maria Paulina, et al.
Publicado: (2023)

Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice
por: Powers, Corey, et al.
Publicado: (2013)

Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis
por: Shen, Yuxiu, et al.
Publicado: (2020)

Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice
por: Russo, Silvia, et al.
Publicado: (2022)

Aim24 and MICOS modulate respiratory function, tafazzin-related cardiolipin modification and mitochondrial architecture
por: Harner, Max Emanuel, et al.
Publicado: (2014)

Mitochondria-Targeted Antioxidant Prevents Cardiac Dysfunction Induced by Tafazzin Gene Knockdown in Cardiac Myocytes
por: He, Quan, et al.
Publicado: (2014)

Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain
por: Hijikata, Atsushi, et al.
Publicado: (2015)

Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis [Retraction]
Publicado: (2020)

Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations
por: Neocleous, Vassos, et al.
Publicado: (2014)

Middle-Aged Lpaatδ-Deficient Mice Have Altered Metabolic Measures
por: Tomczewski, Michelle Victoria, et al.
Publicado: (2022)

A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis
por: Sohn, Jihee, et al.
Publicado: (2022)

Clinical and neurophysiological characteristics of heterozygous NPC1 carriers
por: Benussi, Alberto, et al.
Publicado: (2019)

Correction for The Cardiolipin Transacylase, Tafazzin, Associates with Two Distinct Respiratory Components Providing Insight into Barth Syndrome
Publicado: (2012)

Tafazzin Knockdown in Mice Leads to a Developmental Cardiomyopathy With Early Diastolic Dysfunction Preceding Myocardial Noncompaction
por: Phoon, Colin K. L., et al.
Publicado: (2012)

Cardiolipin content, linoleic acid composition, and tafazzin expression in response to skeletal muscle overload and unload stimuli
por: Fajardo, Val A., et al.
Publicado: (2017)

Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome
por: Petit, Patrice X., et al.
Publicado: (2020)

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
por: Zang, Shuzhi, et al.
Publicado: (2019)

A novel panel of Drosophila TAFAZZIN mutants in distinct genetic backgrounds as a resource for therapeutic testing
por: Richardson, Kristin, et al.
Publicado: (2023)

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
por: Tripodi, Joseph, et al.
Publicado: (2010)

Heterozygous Deletion of the SHOX Gene Enhancer in two Females With Clinical Heterogeneity Associating With Skewed XCI and Escaping XCI
por: Sun, Yixi, et al.
Publicado: (2019)

Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia
por: Silva, Rita Santos, et al.
Publicado: (2022)

Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening
por: Khangura, Sara D., et al.
Publicado: (2021)

NDP-related retinopathies: clinical phenotype of female carriers
por: Huang, Li, et al.
Publicado: (2023)

Comparison of Huntington’s disease phenotype progression in male and female heterozygous FDNQ175 mice
por: Li, Si Han, et al.
Publicado: (2023)

Inorganic Pyrophosphate Plasma Levels Are Decreased in Pseudoxanthoma Elasticum Patients and Heterozygous Carriers but Do Not Correlate with the Genotype or Phenotype
por: Van Gils, Matthias, et al.
Publicado: (2023)

A common cognitive, psychiatric, and dysmorphic phenotype in carriers of NRXN1 deletion
por: Viñas-Jornet, Marina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6seb2m5uvoim5vvbgo0faq4jlg